LAMIVUDINE IP/BP/USP/EP

img

What is Lorem Ipsum?

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

LAMIVUDINE IP/BP/USP/EP

LAMIVUDINE (CAS 134678-17-4) – PRODUCT DESCRIPTION

Lamivudine (CAS 134678-17-4) is an antiviral medication used to treat human immunodeficiency virus (HIV) infection and chronic hepatitis B. It belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs) and works by inhibiting the reverse transcriptase enzyme, which is crucial for the replication of HIV and hepatitis B virus. By blocking this enzyme, Lamivudine prevents the virus from multiplying, helping to reduce viral load and improve immune system function in HIV-infected patients. It is also used as part of combination therapy for HIV/AIDS and is prescribed to manage hepatitis B. This white to off-white crystalline powder is available in pharmaceutical grades (IP/BP/USP/EP), ensuring high purity for use in oral tablets, capsules, and liquid formulations. We supply Lamivudine to pharmaceutical manufacturers, healthcare providers, and research organizations globally, ensuring a reliable and high-quality supply to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

  • Pharmaceuticals (treatment of HIV, hepatitis B, and viral infections)

  • Healthcare (effective as part of combination therapy for HIV/AIDS and hepatitis B)

  • Research (studies on HIV treatment, hepatitis B therapies, and antiviral drug development)

  • Manufacturing (production of oral tablets, capsules, and liquid formulations for HIV and hepatitis B management)

🧪 Available Grades:

  • Pharmaceutical Grade (IP/BP/USP/EP)

  • Reagent Grade

  • Laboratory Grade

⚙️ Functions:

  • Antiviral agent used for the treatment of HIV and hepatitis B

  • Inhibits reverse transcriptase to block HIV and hepatitis B replication

  • Part of combination therapy for HIV/AIDS treatment

  • Reduces viral load and supports immune system function

  • Reagent in antiviral research, HIV treatment studies, and hepatitis B therapies

🧩 Classified Under:

 

  • Pharmaceuticals

  • Antiviral Medications

  • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

  • Active Pharmaceutical Ingredients (APIs)

  • HIV and Hepatitis B Treatments

CAS Number

134678-17-4

Formula

C8H11N3O3S

Molecular Weight

229.26 g/mol

Density

1.4 g/cm³

Gravity

~1.4

Melting Point

~168-170°C

Partical Size

White to off-white crystalline powder